Skip to main content

Table 1 Description of Quality-Assured ACT classifications

From: Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

  First-line quality-assured ACTs: Non first-line quality-assured ACTs:
Definitions Government recommended first-line treatments (regardless of strength) for uncomplicated malaria that appear on the WHO list of approved ACTs or the UNICEF procurement records.
Brands on these lists and audited in each country were:
ACTs that are not the government's recommended first-line treatment for uncomplicated malaria, but which appear on the WHO list of approved ACTs or the UNICEF procurement records.
Brands on these lists and audited in each country were:
Benin Artefan 20/120; Coartem; Lumartem 20/120; Lumet 20/120 Coarsucam; Winthrop
DRC Arsuamoon; Artesunate & Amodiaquine from Ipca; Artesunate & Amodiaquine from Cipla; Falcimon Kit; Serenadose; Coarsucam; Winthrop Artefan 20/120; Coartem 20/120; Lumartem 20/120
Madagascar Arsuamoon; Artesunate & Amodiaquine from Ipca; Actipal 50/153; Winthrop; Coarsucam; Falcimon kit; Larimal Artefan 20/120; Coartem 20/120;
Coartem D 20/120;
Lumartem 20/120
Nigeria Coartem 20/120; Coartem D 20/120; Lumerax 20/120 *Arsuamoon; *Coarsucam; *Larimal Artecospe
Uganda Coartem; Artefan 20/120; Lumartem 20/120 Larimal, Falcimon kit
Zambia Artefan 20/120; Coartem 20/120; Lumartem 20/120; Lumerax; Lumet 20/120 Arsuamoon; Artecospe
  1. *Alternate first-line treatment in Nigeria